Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCSZ11 with Radiation and Chemotherapy in High-risk pMMR Locally Advanced Rectal Cancer
NCT07580339Phase 2Not yet recruiting
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Nov 2026
- Primary completion
- Nov 2030
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of DCSZ11 in rectal cancer, sponsored by Sidney Kimmel Comprehensive Cancer Center. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
DCSZ11
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT07580339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07580339.